Changes in cardiovascular magnetic resonance images by using magnetic resonance imaging scanner at different sites
- Conditions
- Cardiac disease, aortic stenosis, hypertrophic cardiomyopathy, hypertensive heart disease, aortic insufficiency, connective tissue disease of the aorta, heart failure with preserved ejection fraction, muscular dystrophy, inflammatory heart diseaseCirculatory System
- Registration Number
- ISRCTN14627679
- Lead Sponsor
- Charité
- Brief Summary
2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/37574535/ Results of parametric T1 and T2 mapping in healthy volunteers (added 14/08/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 820
1. Aged >18 years
2. Written consent
3. Healthy volunteers, patients with hemodynamic pathologies (aortic stenosis, hypertrophic cardiomyopathy, hypertensive heart disease, aortic insufficiency, and connective tissue disease of the aorta), or systemic disease (heart failure with preserved ejection fraction, muscular dystrophy, and inflammatory heart disease)
1. Healthy volunteers with any known cardiac disease
2. Contraindication to cardiovascular magnetic resonance
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method